TheodoreFeldReissMD

Pulmonology • Nashville, TN

Critical Care Medicine, Pleural Disease

Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Reiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Reiss' full profile

Already have an account?

Office
1161 21st Ave South T-1218 Medical Center North
Vanderbilt University School Of Medicine
Nashville, TN 37232
Phone+1 615-322-3773

Fax+1 615-343-7448
Is this information wrong?

Education & Training

University of California (San Francisco)Residency, Neurological Surgery, 1992 - 1995
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1984
Vanderbilt University School of MedicineClass of 1983

Certifications & Licensure

NJ State Medical License 1991 - 2025
TN State Medical License 2011 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.
Donald H. Arnold, Sara L. Van Driest, Theodore F. Reiss, Jennifer C King, Wendell S Akers> ;Journal of Clinical Pharmacology. 2021 Mar 1
2 citations
Adverse events associated with weight-based, high-dose montelukast exposures in children.
Donald H. Arnold, Nena Bowman, Theodore F Reiss, Tina V. Hartert, Wendell S Akers, Donna Seger> ;Clinical Toxicology. 2020 Feb 1
8 citations
Adverse events are rare after single-dose montelukast exposures in children.
Donald H. Arnold, Nena Bowman, Theodore F Reiss, Tina V. Hartert, Donna Seger> ;Clinical Toxicology. 2018 Jan 1
47 citations
An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine
Curtis H. Weiss, Jerry A. Krishnan, David H. Au, Bruce G. Bender, Shannon S. Carson, Adithya Cattamanchi, Michelle M. Cloutier, Colin R. Cooke, Karen L Erickson, Maure...> ;American Journal of Respiratory and Critical Care Medicine. 2016 Oct 15
36 citations
Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood
Susan Lu, Tina V. Hartert, Mark L. Everard, Hilde Giezek, Linda M. Nelsen, Anish Mehta, Hima Patel, Barbara Knorr, Theodore F. Reiss> ;Pediatric Pulmonology. 2016 May 6
3 citations
BEAR Cage: Mentoring through Engagement
Theodore F Reiss, Joel Moss, Timothy R. Watkins, Atul Malhotra> ;American Journal of Respiratory and Critical Care Medicine. 2016 Apr 1
17 citations
Drug development for airway diseases: looking forward.
Stephen T. Holgate, Alvar Agusti, Robert M. Strieter, Gary P. Anderson, Robert Fogel, Elisabeth H. Bel, Thomas R. Martin, Theodore F Reiss> ;Nature Reviews. Drug Discovery. 2015 May 22
2 citations
Collaborative science and the American Thoracic Society: cooperation in harmony with conflict of interest.
Theodore F. Reiss, Joel Moss, Molly L. Osborne, J. Randall Curtis, Nicholas S. Hill> ;American Journal of Respiratory and Critical Care Medicine. 2012 Dec 14
15 citations
The Asthma Disease Activity Score: A discriminating, responsive measure predicts future asthma attacks
Steven Greenberg, Nancy Liu, Amarjot Kaur, Mani Lakshminarayanan, Yijie Zhou, Linda M. Nelsen, Davis Gates, Wen-Ling Kuo, Steven S. Smugar, Theodore F. Reiss, Neil Bar...> ;The Journal of Allergy and Clinical Immunology. 2012 Nov 1
6 citations
Airway obstruction lability helps distinguish levels of disease activity in asthma
Steven Greenberg, Nancy Liu, Amarjot Kaur, Mani Lakshminarayanan, Yijie Zhou, Linda M. Nelsen, Steven S. Smugar, Gertrude Noonan, Theodore F. Reiss, Barbara Knorr> ;Respiratory Medicine. 2012 Apr 1
16 citations
The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma.
Yasmine S. Wasfi, César Villarán, Celine Le Bailly De Tilleghem, Steven S. Smugar, William D. Hanley, Theodore F. Reiss, Barbara Knorr> ;Respiratory Medicine. 2012 Jan 1
36 citations
Intermittent or daily montelukast versus placebo for episodic asthma in children.
Erkka Valovirta, María Lina Boza, Colin F. Robertson, N. Verbruggen, Steven S. Smugar, Linda M. Nelsen, Barbara Knorr, Theodore F. Reiss, George Philip, Deborah M. Gurner> ;Annals of Allergy, Asthma & Immunology. 2011 Jun 1
8 citations
The Efficacy and Tolerability of Inhaled Montelukast Plus Inhaled Mometasone Compared with Mometasone Alone in Patients with Chronic Asthma
George Philip, César Villarán, Shailen R. Shah, Kristel Vandormael, Steven S. Smugar, Theodore F. Reiss> ;The Journal of Asthma. 2011 May 23
27 citations
MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease.
Jonathan A. Bernstein, Nancy Liu, Barbara Knorr, Steven S. Smugar, William D. Hanley, Theodore F. Reiss, Steven Greenberg> ;Respiratory Medicine. 2011 Mar 1
11 citations
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
George Philip, Andrew Pedinoff, Kristel Vandormael, Yevgen Tymofyeyev, Steven S. Smugar, Theodore F. Reiss, Phillip E. Korenblat> ;The Journal of Asthma. 2010 Nov 18
45 citations
A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder.
Tara L. Frenkl, Haiyuan Zhu, Theodore F. Reiss, Olga Seltzer, Elizabeth Rosenberg, Stuart A. Green> ;The Journal of Urology. 2010 Aug 1
53 citations
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma
Carlos A. Camargo, Deborah M. Gurner, Howard A. Smithline, Rocio Chapela, Leonardo M. Fabbri, Stuart A. Green, Marie-Pierre Malice, Catherine Legrand, S. Balachandra D...> ;The Journal of Allergy and Clinical Immunology. 2010 Feb 1
23 citations
Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Susan Lu, Marie-Pierre Malice, S. Balachandra Dass, Theodore F. Reiss> ;The Journal of Asthma. 2009 Nov 11
48 citations
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
George Philip, Janet van Adelsberg, T. Loeys, Nancy Liu, Peggy H. Wong, Eseng Lai, S. Balachandra Dass, Theodore F. Reiss> ;The Journal of Allergy and Clinical Immunology. 2009 Nov 1
70 citations
Reports of suicidality in clinical trials of montelukast
George Philip, Carolyn M. Hustad, Gertrude Noonan, Marie-Pierre Malice, Alan Ezekowitz, Theodore F. Reiss, Barbara Knorr> ;The Journal of Allergy and Clinical Immunology. 2009 Oct 1
62 citations
Analysis of behavior-related adverse experiences in clinical trials of montelukast
George Philip, Carolyn M. Hustad, Marie-Pierre Malice, Gertrude Noonan, Alan Ezekowitz, Theodore F. Reiss, Barbara Knorr> ;The Journal of Allergy and Clinical Immunology. 2009 Oct 1
5 citations
A Randomized Study Comparing the Effect of Loratadine Added to Montelukast with Montelukast, Loratadine, and Beclomethasone Monotherapies in Patients with Chronic Asthma
Susan Lu, Nancy Liu, S. Balachandra Dass, Theodore F. Reiss> ;The Journal of Asthma. 2009 Jul 21
19 citations
Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial
C.F. Ramsay, Paul Sullivan, Mariusz J. Gizycki, Duolao Wang, A.S. Swern, N.C. Barnes, Theodore F. Reiss, Peter K. Jeffery> ;Respiratory Medicine. 2009 Jul 1
57 citations
Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions
Hans Bisgaard, David P. Skoner, María Lina Boza, Carol A. Tozzi, Kathleen Newcomb, Theodore F. Reiss, Barbara Knorr, Gertrude Noonan> ;Pediatric Pulmonology. 2009 Jun 1
13 citations
Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma
Susan Lu, Nancy Liu, S. Balachandra Dass, Theodore F. Reiss, Barbara Knorr> ;Respiratory Medicine. 2009 Mar 1
Join now to see all

Press Mentions

Chutes & Ladders—Repertoire Immune Medicines, Buzzing from $189M Series B, Taps Celgene Vet as CMOJune 4th, 2021